SABS: SAB Biotherapeutics, Inc Sotuvga nisbatan narx
Global mojarolar va sanksiyalar xomashyo ta'minot zanjirlarini buzishi mumkin bo'lsa-da, avtonom bioreaktorlarning joriy etilishi SAB Biotherapeutics (SABS) uchun antitanalar ishlab chiqarish jarayonida sterillikni ta'minlaydi. Joriy P/S baholashi sotuvlarga bo'lgan bozor talabini aks ettiradi, bunda 1668.60 ushbu metrikaning joriy hajmini ko'rsatadi. Biznes barqarorligi hozirda yagona zardob xarid qilish texnologiyasiga bog'liqlikni kamaytirish uchun diabetga qarshi dori vositalarining sinov natijalariga tayanmoqda.
SAB Biotherapeutics, Inc (SABS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati SAB Biotherapeutics|SABS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati SAB Biotherapeutics Inc|SABS - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati SAB Biotherapeutics, Inc|SABS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi SAB Biotherapeutics|Shoshilinch likvidlik sabbiotherapeutics.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
SABS - Sof daromad|Kelajakdagi sof foyda SAB Biotherapeutics|SABS - P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori SAB Biotherapeutics Inc.|SABS - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati SAB Biotherapeutics, Inc|SABS - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda SAB Biotherapeutics|SABS - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi sabbiotherapeutics.com|SABS - Joriy yilda bir aksiya uchun foyda o'sishi|Kelgusi yil uchun bir aksiya uchun sof foydaning o'zgarishi prognozi SAB Biotherapeutics
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:sabbiotherapeutics.com SABS
P/S koeffitsienti biznesning bozor qiymatini uning yillik daromadiga nisbatan belgilaydi va investorlarning sotuvlar birligi uchun to'lashga bo'lgan tayyorligini o'lchaydi. SAB Biotherapeutics (SABS) uchun ushbu metrika DiversitAb platformasining tijoratlashtirilishi va diabet terapiyasi borasidagi muvaffaqiyatlarga oid kutishlarni aks ettiradi. Narx/sotuvlar koeffitsiyenti darajasini tahlil qilish orqali kelajakdagi daromad potentsialining qanchalik qismi narxga kiritilganini baholash mumkin. Ushbu metrika aktivning haddan tashqari sotib olinganligini aniqlash uchun juda muhimdir.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti Protagonist Corp PTGX|IMVT: P/S multiplikatori|kiniksa.com (KNSA) - P/S multiplikatori|GRFS (Grifols) - P/S multiplikatori|Narxning daromadga nisbati ADPT|Kapitalizatsiyaning daromadga nisbati CLDX (Celldex)|AUPH (Aurinia Corp) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori BCRX (BioCryst)|veratx.com - Narxning daromadga nisbati|Dianthus Therapeutics, Inc. - P/S multiplikatori|Narx/daromad koeffitsiyenti Pharvaris NV PHVS|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|Sotuvga nisbatan narx Tourmaline (TRML)|Kapitalizatsiyaning daromadga nisbati PGEN|PHAR (pharming.com) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori NKTR|UPB (Upstream Bio, Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Immunome Bio (IMNM) - Sotuvga nisbatan narx|GOSS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KALV (kalvista.com)|SEPN: P/S multiplikatori|Pieris Pharma (PVLA) - P/S multiplikatori|Narxning daromadga nisbati Savara Corp|Rigel Corp - Narxning sotuvga nisbati|P/S multiplikatori ANAB|ATXS - Sotuvga nisbatan narx|enGene - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori RAPT Therapeutics Inc. RAPT|JBIO: Kapitalizatsiyaning daromadga nisbati|Aclaris Therapeutics, Inc - Kapitalizatsiyaning sotish hajmiga nisbati|KYTX: P/S multiplikatori|TLSA - Narx/daromad koeffitsiyenti|CABA (Cabaletta Bio) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Ventyx Biosciences Inc. (VTYX)|Narxning daromadga nisbati Theratechnologies Inc (THTX)|Narx/daromad koeffitsiyenti Avalo Therapeutics Inc|Narxning daromadga nisbati Eledon Pharmaceuticals ELDN|Narx/daromad koeffitsiyenti agenusbio.com (AGEN)|Climb Bio - P/S multiplikatori|ZURA - P/S multiplikatori|ATYR: P/S multiplikatori|ADAG (Adagene Inc.) - Narxning daromadga nisbati|Narxning daromadga nisbati ImageneBio|Shattuck Therapeutics (STTK) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Equillium, Inc. (EQ)|CNTB: Narxning sotuvga nisbati|P/S multiplikatori IMUX (Immunic)|Bozor kapitallashuvining daromadga nisbati ATRA|InflaRx GmbH - P/S multiplikatori|XFOR - P/S multiplikatori|adicetbio.com (ACET) - Narxning daromadga nisbati|Celularity - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati INmune Bio Corp|Kapitalizatsiyaning daromadga nisbati Barinthus Biotherapeutics Corp (BRNS)|P/S multiplikatori KZR|P/S multiplikatori akaritx.com (AKTX)|Enlivex Therapeutics Ltd. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati QTTB|GeoVax Labs Inc - P/S multiplikatori|Narx/daromad koeffitsiyenti Edesa Biotech Corp EDSA|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Carisma Therapeutics Inc.|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiyaning daromadga nisbati Bolt Bio (BOLT)|Kapitalizatsiyaning daromadga nisbati HCWB (HCW Biologics Inc.)|P/S multiplikatori aptevotherapeutics.com (APVO)|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX: Kapitalizatsiya va daromad nisbati|GRI Bio - P/S multiplikatori|Sotuvga nisbatan narx XORTX Therapeutics Inc|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|REVB - Narx/daromad koeffitsiyenti|INDP (Indaptus Therapeutics) - P/S multiplikatori|P/S multiplikatori scinai.com|P/S multiplikatori CALI|Narxning daromadga nisbati AFMD (affimed.com)|Allakos - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati HOOK|IGM Bio - P/S multiplikatori|ITOS: Narxning daromadga nisbati|OCEA: P/S multiplikatori|TCBP - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati Third Harmonic Bio, Inc
